Background Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterised by remarkable cellular ...

Promoting brown fat activity could counteract hypertension by reshaping the molecular signals that govern vascular stiffness.

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

Some antibiotics stop bacteria from growing without actually killing them, allowing infections to return later. Scientists at ...

A shift in the balance between two lipids – cholesterol and sphingomyelin – makes hybrid epithelial-mesenchymal cancer cells less responsive to certain chemotherapy drugs.

Lipid imbalance triggered by Snail-driven epithelial–mesenchymal transition creates a cholesterol-dependent vulnerability that can be therapeutically targeted to overcome chemoresistance in cancer.

This video explains how the dollar sign is used in Excel formulas to control whether cell references stay fixed or change ...

This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock performance.

The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...

DNA doesn’t just sit still inside our cells — it folds, loops, and rearranges in ways that shape how genes behave.